Cita APA

Albanell Mestres, J., Comerma Blesa, L., Gibert Fernandez, J., Bellosillo Paricio, B., Menéndez, S., & Llombart-Cussac, A. (2023). Palbociclib rechallenge for hormone receptor-positive/HER-negative advanced breast cancer: Findings from the phase II BioPER trial.

Citación estilo Chicago

Albanell Mestres, Joan, Laura Comerma Blesa, Joan Gibert Fernandez, Beatriz Bellosillo Paricio, Silvia Menéndez, y Antonio Llombart-Cussac. Palbociclib Rechallenge for Hormone Receptor-positive/HER-negative Advanced Breast Cancer: Findings From the Phase II BioPER Trial. 2023.

Cita MLA

Albanell Mestres, Joan, et al. Palbociclib Rechallenge for Hormone Receptor-positive/HER-negative Advanced Breast Cancer: Findings From the Phase II BioPER Trial. 2023.